Clinical Trials Browser

Completed × Leuprolide × Breast × Clear all

NCT03056755 2026-01-13

BYLieve

Phase 2 Completed

383 enrolled 16 charts

Breast Neoplasms, Hereditary Sensory and Autonomic Neuropathies

NCT05122377 2026-01-06

RWE About QOL and Compliance of Patients With OFS in China

Breast Neoplasms, Patient Compliance

NCT03272477 2024-04-17

TP-II

Phase 2 Completed

Breast Neoplasms

NCT02941926 2023-10-24

COMPLEEMENT-1

Phase 3 Completed

3,246 enrolled 11 charts

Breast Neoplasms

NCT01989780 2022-08-04

BOOSTER

Phase 2 Completed

Breast Neoplasms

NCT02344550 2020-07-30

LEO

Phase 2 Completed

Breast Neoplasms

NCT03209518 2019-11-01

Special Drug Use Surveillance of Leuprorelin for Injection Kit 22.5 mg in "Premenopausal Breast Cancer"

312 enrolled 17 charts

Premenopausal Breast Cancer

NCT02980965 2017-11-13

Neoadjuvant Chemo-endocrine Therapy Versus Chemotherapy Alone in ER-positive, HER2-negative Breast Cancer

Phase 3 Completed

Breast Neoplasms

NCT02134977 2016-10-18

Leuplin SR 11.25 mg Injection Kit Specified Drug-use Survey: "QOL Survey in Premenopausal Breast Cancer Patients"

2,816 enrolled 29 charts

Breast Neoplasms

NCT00903162 2016-04-18

Extended Endocrine Therapy for Premenopausal Women With Breast Cancer

Phase 2 Completed

17 enrolled 5 charts

Breast Neoplasms

NCT02154139 2016-02-17

Leuprorelin Acetate SR 11.25 mg for Injection Specified Drug-use Survey "Long-term Use Survey on Premenopausal Breast Cancer Patients (96 Weeks)"

651 enrolled 12 charts

Breast Neoplasms

NCT00002580 2013-11-06

Tamoxifen, Ovarian Ablation, and/or Combination Chemotherapy in Treating Premenopausal Women With Stage I, Stage II, or Stage IIIA Invasive Breast Cancer

Phase 3 Completed

Breast Neoplasms

NCT00002582 2013-08-02

Tamoxifen, Ovarian Ablation, and/or Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer

Phase 3 Completed

Breast Neoplasms